Wallace Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.49M | Buy |
2,990
+90
| +3% | +$44.8K | 1.08% | 19 |
|
|
2025
Q1 | $1.51M | Sell |
2,900
-42
| -1% | -$21.9K | 1.04% | 19 |
|
|
2024
Q4 | $1.82M | Sell |
2,942
-42
| -1% | -$26K | 1.26% | 14 |
|
|
2024
Q3 | $1.65M | Sell |
2,984
-37
| -1% | -$20.5K | 1.21% | 16 |
|
|
2024
Q2 | $1.67M | Buy |
3,021
+1,078
| +55% | +$596K | 1.2% | 17 |
|
|
2024
Q1 | $1.03M | Sell |
1,943
-276
| -12% | -$146K | 0.77% | 33 |
|
|
2023
Q4 | $1.12M | Sell |
2,219
-124
| -5% | -$62.8K | 0.88% | 25 |
|
|
2023
Q3 | $1.22M | Buy |
2,343
+259
| +12% | +$135K | 0.88% | 26 |
|
|
2023
Q2 | $1.2M | Hold |
2,084
| – | – | 0.91% | 26 |
|
|
2023
Q1 | $1.2M | Sell |
2,084
-90
| -4% | -$51.9K | 0.91% | 26 |
|
|
2022
Q4 | $1.2M | Buy |
+2,174
| New | +$1.2M | 0.95% | 20 |
|